Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Denali Therapeutics right now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
3.7282 of 5 stars
$16.11+0.8%N/A-14.92Buy$41.22
Ultragenyx Pharmaceutical (RARE)
4.4467 of 5 stars
$45.11+3.3%N/A-5.42Moderate Buy$90.33
Sarepta Therapeutics (SRPT)
4.8821 of 5 stars
$117.12+0.1%N/A-19.14Moderate Buy$158.38
Pfizer (PFE)
4.9942 of 5 stars
$26.32+0.2%6.38%73.11Hold$36.33
Exelixis (EXEL)
4.99 of 5 stars
$23.29+1.8%N/A36.39Moderate Buy$26.29
Moderna (MRNA)
3.9826 of 5 stars
$107.89+3.3%N/A-8.69Hold$126.49
United Therapeutics (UTHR)
4.7793 of 5 stars
$234.47+0.2%N/A11.82Moderate Buy$294.25
Biogen (BIIB)
4.927 of 5 stars
$193.18-0.5%N/A24.21Moderate Buy$295.58
Sanofi (SNY)
3.0802 of 5 stars
$47.69+1.1%2.89%20.21Hold$55.00
Eli Lilly and Company (LLY)
4.8483 of 5 stars
$745.62+2.0%0.70%128.56Moderate Buy$728.05
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Crafting Your Portfolio's Magnificent Seven: Top Stocks for 2024

Crafting Your Portfolio's Magnificent Seven: Top Stocks for 2024

MarketBeat gives you seven stocks that you should be looking at to create your own Magnificent Seven in 2024.

Search Headlines: